Submit Deal

Leonard Schleifer

CEO and President at REGENERON

Manager

Deal Bio

Total Deals4

Valued Deals4

Total Value£5,225M

Avg. Deal Size£1,306M

Market Context

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

Expertise

Key Relationships (4)

Sort

United States

Biotechnology

AcquisitionTender OfferPublicMajorityDomesticPrivate Equity

target

REGENERON

bidder

Institutional Investors

£3,989m

23 dealmakers

United States

Biotechnology

AcquisitionMajorityPublicDomestic

target

Checkmate Pharmaceuticals

bidder

REGENERON

£191m

62 dealmakers

United States

Pharmaceuticals

MajorityPrivateAcquisitionDomestic

target

LIBTAYO

bidder

REGENERON

£876m

16 dealmakers

United States

Biotechnology

AcquisitionMajorityDomesticPublic

target

Decibel Therapeutics

bidder

REGENERON

£167m

24 dealmakers

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy